Treatment of Hodgkin's disease: The Swedish national care programme experience

被引:29
作者
Glimelius, B
Enblad, G
Kalkner, M
Gustavsson, A
Jakobsson, M
Branehog, I
Lenner, P
Bjorkholm, M
机构
[1] Department of Oncology, Regional Oncological Centre, Uppsala University, Uppsala
[2] Department of Oncology, Regional Oncological Centre, University Hospital, Lund
[3] Department of Oncology, Regional Oncological Centre, Linköping University, Linköping
[4] Department of Oncology, Regional Oncological Centre, Gothenburg University, Stockholm
[5] Department of Oncology, Regional Oncological Centre, Umeå University, Umeå
[6] Department of Medicine, Karolinska Hospital and Institute, Stockholm
[7] Department of Oncology, Akademiska Sjukhuset
关键词
Hodgkin's disease; national care programme; elderly patients; chemotherapy; radiotherapy;
D O I
10.3109/10428199609067582
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Since 1985 a Swedish National Care Programme has provided tailored principles for the diagnosis, staging, treatment and follow-up of patients with Hodgkin's disease (HD). This report gives the rationale behind the recommendations and presents treatment results for 648 patients diagnosed between 1985 and 1989 after a median follow-up of 70 months. Two hundred and twenty-nine (35%) patients were over 60 years of age. Treatment results for patients below 60 years of age in early and intermediate stages were favourable, provided the recommendations were followed. In advanced stages, the outcome was inferior in patients with CS IIB bulky disease and stage IVB. The prognosis of elderly patients remains poor, although it is too early to evaluate any impact of revisions made in 1989, The tailored principles, which usually entail less staging and/or treatment than is generally the case in the early and intermediate stages, produced favourable results when applied to an unselected group of patients with HD. Only minor changes were made in the recommendations during the 1994 revision.
引用
收藏
页码:71 / 78
页数:8
相关论文
共 27 条
[1]   CHEMOTHERAPY OF ADVANCED HODGKINS-DISEASE WITH MOPP, ABVD, OR MOPP ALTERNATING WITH ABVD [J].
CANELLOS, GP ;
ANDERSON, JR ;
PROPERT, KJ ;
NISSEN, N ;
COOPER, MR ;
HENDERSON, ES ;
GREEN, MR ;
GOTTLIEB, A ;
PETERSON, BA .
NEW ENGLAND JOURNAL OF MEDICINE, 1992, 327 (21) :1478-1484
[2]  
CARBONE PP, 1971, CANCER RES, V31, P1860
[3]  
CARELLA AM, 1991, BONE MARROW TRANSPL, V8, P99
[4]  
CONNORS JM, 1987, SEMIN HEMATOL, V24, P35
[5]  
CONNORS JM, 1993, PRINCIPLES PRACTICE, V2, P1
[6]   CURABILITY OF ADVANCED HODGKINS-DISEASE WITH CHEMOTHERAPY [J].
DEVITA, VT ;
SIMON, RM ;
HUBBARD, SM ;
YOUNG, RC ;
BERARD, CW ;
MOXLEY, JH ;
FREI, E ;
CARBONE, PP ;
CANELLOS, GP .
ANNALS OF INTERNAL MEDICINE, 1980, 92 (05) :587-595
[7]  
DEVITA VT, 1993, NEW ENGL J MED, V328, P560
[8]  
DEVITA VT, 1993, PRINCIPLES PRACTICE, V1, P1
[9]   TREATMENT OUTCOME IN HODGKINS-DISEASE IN PATIENTS ABOVE THE AGE OF 60 - A POPULATION-BASED STUDY [J].
ENBLAD, G ;
GLIMELIUS, B ;
SUNDSTROM, C .
ANNALS OF ONCOLOGY, 1991, 2 (04) :297-302
[10]   TREATMENT OF EARLY AND INTERMEDIATE STAGES OF SUPRADIAPHRAGMATIC HODGKINS-DISEASE - THE SWEDISH NATIONAL CARE PROGRAM EXPERIENCE [J].
GLIMELIUS, B ;
KALKNER, M ;
ENBLAD, G ;
GUSTAVSSON, A ;
JAKOBSSON, M ;
BRANEHOG, I ;
LENNER, P .
ANNALS OF ONCOLOGY, 1994, 5 (09) :809-816